Skip to main content
OpenTrials
Completed

NCT Number: NCT03284450

Exercise Induced Muscle Damage Post Dance and Sprint Specific Exercise in Females

There is a paucity of studies investigating exercise-induced muscle damage (EIMD) in females and only one in response to dance-type exercise. This study aimed to firstly elucidate the physiological profile of EIMD following a dance-specific protocol, and second to compare the magnitude of damage to that experienced following a sport-specific protocol in physically active females.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–25 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

About this study

Twenty nine female recreational dancers from a University dance team volunteered to take part in the study. A 3-day food diary and activity log completed prior to testing determined that there were no differences in physical activity levels or energy and macronutrient intakes between participants. Subjects were asked to replicate their reported diets as closely as possible throughout the testing period. A menstrual cycle questionnaire was also completed in order to determine menstrual cycle phase; all testing took place during the early/mid luteal phase.

Participants were randomly assigned to two exercise groups designed to induce EIMD; either a dance-specific protocol (DPFT) or a sport-specific repeated sprint protocol (SSRS). Participants completed the DPFT (n=15) or SSRS (n=14) and a battery of commonly used muscle damage indices were measured pre, immediately post and 24-, 48-, and 72 h post muscle damage. These were; delayed onset muscle soreness (DOMS), limb girth, countermovement jump height (CMJ), reactive strength index (RSI), maximal voluntary isometric contraction (MVC) sprint performance, and total creatine kinase (CK) activity. Participants were tested at the same time on subsequent days (± 1 h) to account for diurnal variation. Participants were asked to avoid strenuous exercise, alcohol, caffeine, nutritional supplements and any anti-inflammatory drugs or alternative treatments for the duration of the study.

Statistical software (IBM SPSS v21, IBM, USA) was used for inferential analysis and significance was accepted at the P < .05 a priori. Mauchley's test assessed the sphericity of the data and where appropriate, violations were corrected using the Greenhouse-Geisser. To explore our first objective, a one-way analysis of variance (ANOVA) with repeated measures (group, 1; time, 5) was performed on all variables in order to analyse the muscle damage response to the DPFT. For the second aim a two-way ANOVA with repeated measures (group, 2; time, 5) was used for all variables to allow for comparison of the muscle damage response between the DPFT and the SSRS. Where appropriate LSD post-hoc analysis was performed.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • physically active
  • at least 3 years experience in dance training

Exclusion criteria

  • presence of any medical or physical conditions, either chronic or sustained in the last 3 months which would make participation difficult or harmful to the participant
  • eg. history of cardiovascular disease and musculoskeletal disorders

Treatment and study plan

DPFT

Other

The DPFT described previously (Redding et al., 2009) involves the repetition of a 'dance phrase' representative of contemporary dance, with each phrase separated by a 2 minute rest period. For the present study the originally described test was extended; the adapted protocol involved 10 x 1 minute movement phrases, each separated by 2 minutes rest.

SSRS

Other

The SSRS (Howatson & Milak, 2009) involved 15 x 30 m sprints with a rapid 10 m deceleration phase, with each sprint departing every 65 seconds.

Primary outcomes

  1. Change in maximum voluntary contraction (MVC)

    Time frame: Change from pre exercise MVC at 24 h post exercise

    Isometric MVC of the participants' dominant knee extensors was assessed using a strain gauge.

Secondary outcomes

  1. Limb girths

    Time frame: pre, immediately post (0) and 24-, 48-, and 72 h post exercise

    Lower limb girths at the calf and mid-thigh of the right leg were recorded as measures of muscle swelling. Both locations were marked with permanent marker to ensure consistency on consecutive days.

  2. Countermovement jump

    Time frame: pre, immediately post (0) and 24-, 48-, and 72 h post exercise

    Countermovement jump height was recorded using a light timing system.

  3. Reactive strength index

    Time frame: pre, immediately post (0) and 24-, 48-, and 72 h post exercise

    Participants performed a drop jump from a 30cm height to determine reactive strength index

  4. Muscle soreness

    Time frame: pre, immediately post (0) and 24-, 48-, and 72 h post exercise

    Subjective muscle soreness was measured using a 200 mm visual analogue scale from 'no soreness' to 'unbearably sore.' Participants were required to indicate on the line the level of perceived active lower limb soreness felt during a 90 degree squat.

  5. 30 m sprint time

    Time frame: pre, immediately post (0) and 24-, 48-, and 72 h post exercise

    Participants completed a single maximal effort 30 m sprint where sprint time was recorded. The sprint was initiated from a line 30 cm behind the start line in order to prevent false triggering of the timing gates.

  6. Creatine Kinase

    Time frame: pre, immediately post (0) and 24-, 48-, and 72 h post exercise

    Blood samples were collected via venepuncture from the antecubital fossa area in to a 10 ml EDTA vacutainer. The samples were centrifuged at 3000 RCF for 15 minutes at 4 C. Plasma was extracted, and stored immediately at -80 C for later analysis. Plasma CK concentrations were determined spectrophotometrically.

Sponsors and collaborators

Lead sponsor

Northumbria University

Other

Registry information

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Sep 15, 2017
Registry last updated
Sep 15, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.